Parallel Advisors’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-345
| Closed | -$1.64K | – | 3387 |
|
2023
Q2 | $1.64K | Buy |
345
+191
| +124% | +$909 | ﹤0.01% | 2807 |
|
2023
Q1 | $878 | Sell |
154
-321
| -68% | -$1.83K | ﹤0.01% | 2986 |
|
2022
Q4 | $4.79K | Buy |
475
+230
| +94% | +$2.32K | ﹤0.01% | 2362 |
|
2022
Q3 | $5K | Buy |
245
+59
| +32% | +$1.2K | ﹤0.01% | 2267 |
|
2022
Q2 | $5K | Buy |
186
+89
| +92% | +$2.39K | ﹤0.01% | 2239 |
|
2022
Q1 | $4K | Sell |
97
-25
| -20% | -$1.03K | ﹤0.01% | 2346 |
|
2021
Q4 | $7K | Buy |
122
+98
| +408% | +$5.62K | ﹤0.01% | 2243 |
|
2021
Q3 | $1K | Buy |
24
+8
| +50% | +$333 | ﹤0.01% | 2828 |
|
2021
Q2 | $1K | Sell |
16
-16
| -50% | -$1K | ﹤0.01% | 2699 |
|
2021
Q1 | $3K | Buy |
32
+20
| +167% | +$1.88K | ﹤0.01% | 2340 |
|
2020
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 2399 |
|
2019
Q4 | – | Sell |
-76
| Closed | -$1K | – | 2424 |
|
2019
Q3 | $1K | Hold |
76
| – | – | ﹤0.01% | 2256 |
|
2019
Q2 | $2K | Buy |
+76
| New | +$2K | ﹤0.01% | 2059 |
|
2017
Q1 | – | Sell |
-25,000
| Closed | -$63K | – | 2012 |
|
2016
Q4 | $63K | Buy |
+25,000
| New | +$63K | 0.01% | 515 |
|